0001209191-20-013029.txt : 20200226
0001209191-20-013029.hdr.sgml : 20200226
20200226163408
ACCESSION NUMBER: 0001209191-20-013029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200224
FILED AS OF DATE: 20200226
DATE AS OF CHANGE: 20200226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20656272
MAIL ADDRESS:
STREET 1: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-24
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
CEO & President
Common Stock
2020-02-24
4
F
0
8410
239.23
D
103131
D
Common Stock
2020-02-25
4
S
0
2273
229.77
D
100858
D
Common Stock
2020-02-25
4
S
0
1120
230.40
D
99738
D
Common Stock
2020-02-25
4
S
0
1050
231.76
D
98688
D
Common Stock
2020-02-25
4
S
0
1017
232.96
D
97671
D
Common Stock
2020-02-25
4
S
0
1640
234.49
D
96031
D
Common Stock
2020-02-25
4
S
0
1210
235.53
D
94821
D
Common Stock
2020-02-25
4
S
0
560
236.63
D
94261
D
Common Stock
2020-02-25
4
S
0
1680
238.33
D
92581
D
Common Stock
440
I
401(k)
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $229.77 (range $229.07 to $230.00).
Open market sales reported on this line occurred at a weighted average price of $230.40 (range $230.14 to $230.73).
Open market sales reported on this line occurred at a weighted average price of $231.76 (range $231.27 to $232.14).
Open market sales reported on this line occurred at a weighted average price of $232.96 (range $232.27 to $233.11).
Open market sales reported on this line occurred at a weighted average price of $234.49 (range $233.99 to $234.66).
Open market sales reported on this line occurred at a weighted average price of $235.53 (range $235.07 to $235.72).
Open market sales reported on this line occurred at a weighted average price of $238.33 (range $238.16 to $238.56).
/s/ Omar White, Attorney-in-Fact
2020-02-26